A rapid, simple determination of plasma cyclic AMP

Area of Science:

• Biochemistry
• Pharmacology

Background:

• Cyclic adenosine monophosphate (cAMP) is a crucial second messenger involved in various cellular processes.
• Accurate measurement of plasma cAMP levels is essential for understanding physiological and pharmacological responses.

Purpose of the Study:

• To develop and validate a direct assay for quantifying plasma cyclic adenosine monophosphate (cAMP) without prior extraction.
• To assess the utility of this direct assay in a physiological context, specifically in response to isoproterenol administration.

Main Methods:

• A direct radioimmunoassay using a binding protein from rat liver was employed for plasma cAMP determination.
• Ethylenediaminetetraacetic acid (EDTA) was utilized as an anticoagulant, and its suitability for cAMP estimation was confirmed.
• Assay validation included assessing recovery after adding cAMP to plasma and evaluating plasma dilution effects.

Main Results:

• The direct assay demonstrated accurate estimation of added cAMP and consistent values upon plasma dilution, indicating its reliability.
• Administration of isoproterenol (50 µg/kg, IV) in anesthetized dogs led to a significant increase in plasma cAMP levels.
• Isoproterenol also induced physiological changes, including decreased blood pressure and increased heart rate.
• Baseline plasma cAMP levels varied across species: human (18.6 ± 1.32 pmol/ml), dog (21.6 ± 3.04 pmol/ml), and rabbit (50.6 ± 4.59 pmol/ml), with rabbits exhibiting higher levels.

Conclusions:

• The developed direct assay for plasma cyclic adenosine monophosphate (cAMP) is a valid and practical method for its determination.
• This assay can effectively measure changes in plasma cAMP levels in response to pharmacological stimuli, such as isoproterenol.
• Species-specific differences in baseline plasma cAMP levels were observed, highlighting the importance of considering species in physiological studies.